APA (7th ed.) Citation

L, J., EH, C., P, F., J, K., K, V., M, M., . . . LO, J. (2023). Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 101(1), 13. https://doi.org/10.1002/ccd.30480

Chicago Style (17th ed.) Citation

L, Jakobsen, et al. "Impact of Acute Coronary Syndrome on Clinical Outcomes After Revascularization with the Dual-therapy CD34 Antibody-covered Sirolimus-eluting Combo Stent and the Sirolimus-eluting Orsiro Stent." Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions 101, no. 1 (2023): 13. https://doi.org/10.1002/ccd.30480.

MLA (9th ed.) Citation

L, Jakobsen, et al. "Impact of Acute Coronary Syndrome on Clinical Outcomes After Revascularization with the Dual-therapy CD34 Antibody-covered Sirolimus-eluting Combo Stent and the Sirolimus-eluting Orsiro Stent." Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions, vol. 101, no. 1, 2023, p. 13, https://doi.org/10.1002/ccd.30480.